Science1 distinct publisher3 min readUpdated
Two tick-borne viruses with at least seven US deaths between them are moving with the lone star tick, and diagnosis depends on a hospital deciding to ship blood to a specialised lab.
The Scientist · Science desk

Compiled by The ScientistSomething wrong?How this is made
Two tick-borne viruses with at least seven US deaths between them are moving with the lone star tick, and diagnosis depends on a hospital deciding to ship blood to a specialised lab.
Nebraska has become the ninth US state to detect Heartland virus, Bourbon virus or both in local ticks, and New York has reported its first human Bourbon virus infection [1][2][3]. Between them the two viruses have killed at least seven people in the US, and there is no commercial test for either, so a case is only found when a hospitalised patient's blood is sent to a specialised laboratory such as the Centers for Disease Control and Prevention [1][4].
Both viruses are carried by the lone star tick, Amblyomma americanum [5]. That tick was historically confined to southeastern states but has been pushing north and west, which New Scientist attributes to factors including climate change and reforestation of previously cleared land [6]. Heartland or Bourbon virus has now been found in lone star ticks in Missouri, Kansas, Illinois, Alabama, Georgia, New York, Pennsylvania and Virginia [7]; adding Nebraska makes nine [1][1].
The Nebraska finding came from screening more than 7000 lone star ticks collected by the state Department of Health and Human Services at multiple locations between 2022 and 2026 [8]. Both viruses turned up in ticks from Sarpy County, and Heartland virus in ticks from Richardson County, both in the southeast of the state, consistent with ticks arriving from neighbouring Missouri and Kansas [9]. No Nebraskan is known to have caught either virus, but Joseph Fauver of the University of Nebraska Medical Center says there is a "very real possibility" that infections have occurred and gone undiagnosed, because the symptoms look like other tick-borne or ordinary viral illnesses: fever, fatigue, headache, appetite loss, muscle or joint aches and nausea [10][11][12].
The surveillance gap is the operative problem. Only a small proportion of infected people become severely unwell [13], and blood samples from hundreds of people in Missouri found almost 1 per cent with neutralising antibodies to Heartland and Bourbon virus, indicating past infection [14]. Fauver cautions that this does not mean 1 per cent of Missourians have had these illnesses [15]. Against that background, more than 80 Heartland infections have been identified across central and eastern states, with at least four deaths [16] - a crude ratio of roughly 5 per cent among detected cases, which says more about who gets tested than about the virus [2].
The severe cases are what drives detection. Heartland virus was named for the Heartland Regional Medical Center in St Joseph, Missouri, where it was found in 2012 in two farmers hospitalised after tick bites; both recovered, one with fatigue and headaches lasting years [17][18]. The most recent Heartland death, reported last October, was a 32-year-old Connecticut woman who died of cardiac arrest after a hiking trip; an autopsy found the virus in her brain [19]. Bourbon virus is named for Bourbon County, Kansas, where a man who found a tick on his shoulder in 2014 died of multi-organ failure [20]. The New York patient, a man in his 60s bitten by multiple ticks while working outdoors on Long Island, recovered, and was identified only because his blood went to the state Department of Health [21][22].
Watch whether Nebraska logs a first human case now that clinicians there have a reason to ask, whether tick-positive counties move beyond the two southeastern ones, and whether any diagnostic reaches clinicians outside the referral-to-CDC pathway.
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
Nebraska has become the ninth US state to detect Heartland virus, Bourbon virus or both in local ticks; the two viruses have killed at least seven people in the US and appear to be spreading.
New York recently reported its first case of Bourbon virus in a person.
Heartland virus was first reported in 2012 and Bourbon virus in 2015, after both were found in people who became severely unwell or died following tick bites.
There are no commercial tests for Heartland virus or Bourbon virus, so they are only detected when blood samples from hospitalised patients are sent for analysis at specialised laboratories such as the CDC.
Both viruses have been found to be transmitted by lone star ticks (Amblyomma americanum), named for the white, vaguely star-shaped spot on the female's back.
Lone star ticks were historically found only in southeastern US states but have been pushing further north and west due to factors like climate change and reforestation of previously cleared areas.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Specific primary findings, single publisher, no study citation
The reporting is concrete and internally consistent: named researcher and institution, a named collecting agency, a stated sample size and collection window, named counties, named case histories, and a seroprevalence figure with the researcher's own caveat attached. That specificity is what lifts the score above the midpoint. What holds it down is that every claim in the cluster rests on one publisher's account, the underlying Nebraska tick study is neither linked nor described as peer reviewed, and the only voices are researchers directly involved in the Nebraska and New York findings.
No adoption-type evidence supplied
This is a pathogen-surveillance story, and the supplied source contains no release, deployment, procurement, pricing or usage-disclosure event that adoption could be measured against. The nearest analogue - uptake of specialised testing - is described only qualitatively as depending on individual hospitals shipping samples, with no volumes or rates given, so no adoption value is inferred.
Headline spread framing runs slightly ahead of the case numbers
Slightly overstated rather than inflated. The framing that deadly viruses are spreading is supported by tick detections across nine states plus a new human case in New York, but the human burden described is small in absolute terms - at least seven deaths across both viruses and 80-plus detected Heartland infections - and Nebraska has no known human case at all. The article partly self-corrects by carrying the researcher's caveats that only a small proportion of infections become severe and that 1 per cent seroprevalence is not 1 per cent illness, which is why the gap is modest.
Mild researcher interest in continued surveillance, disclosed in text
The principal source of nearly every claim is the investigator whose team produced the finding and who states that continuous monitoring is crucial and that his group will retest the Nebraska sites, and the New York case reaches the reader via a university press release quoted in the article. Those are visible interests in sustained surveillance attention. They are scored low because the incentives are apparent on the face of the reporting, the factual claims are specific and falsifiable, and the same sources volunteer limiting caveats against their own strongest numbers.
Coherent single-source reporting, no corroboration or adoption signal
Confidence is moderate. The claim set is detailed, mutually consistent and largely attributable to named people and agencies, so the core facts are probably reliable. But one publisher supplies everything, the underlying study is uncited, adoption is unmeasurable from the supplied material, and the most decision-relevant proposition - that undiagnosed human infections are already occurring - is expert conjecture without supporting data.
science
STAR puts the proton's baryon number on a gluon junction, not on its three quarks1 distinct publisher
science
A spreading PX1 cluster in Uganda dulls both drugs in Africa's front-line malaria pill1 distinct publisher
science
STAR puts the proton's baryon number on a gluon junction, not on its three quarks1 distinct publisher
science
A tetanus-diphtheria shot that sat at 30C for a year worked. Now the paperwork is the bottleneck.1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 20, 2026